In light of the incessant healthcare talk and reform on the imminent horizon, we’ve lately had fun discovering tiny new companies that illustrate some of the under-the-radar efforts of the medical community that might help reduce the cost of what has become a behemoth. (Oh, Congress, are you listening?) This week, that company [...]
Noted with increasing frequency of late are the healthcare implications of the aging baby boomer generation. Everything from Medicare costs to drug development direction will be affected by this trend, and our own clients in the medical devices space are practically giddy with anticipation. Indeed, the device market is expected to double within [...]
According to recent numbers, 50% of all Americans are prescribed approximately one pill per day. That’s a lot of people, a lot of pills, and undoubtedly many, many missed doses. These days, remembering to take your pills is often even more difficult than getting them, especially for senior citizens.
Massachusetts-based Vitality, Inc. has [...]
Last week, trial-matching platform developer Healogica announced the availability of a new iPhone app that allows potential patients to search for clinical trials via the mobile web. Only $.99 to download, Clinical Trials 2.0 is an extension of Healogica’s current website, which provides a database for patients to search and connect with trials based [...]
Late last week, a little company in Newport, R.I. made a big announcement; namely, that it had nabbed $11.6 million in a Series A funding round for its snake robot technology for minimally-invasive surgical procedures. Given the severely sluggish VC market and what feels like a dearth of new deals the past two quarters, this [...]
There’s good news today for the more than 30,000 people receiving life-saving kidney transplants globally each year. Carlsbad, California-based Invitrogen aims to improve life after transplant with a new biomarker tool that addresses two chronic and life-threatening challenges: kidney rejection triggered by the graft and the cumulative cell and tissue damage caused by immunosuppressive drugs [...]
Waltham, MA-based medical device company Augmenix has allegedly sealed up $4.7 million of a planned $7.5 million round of funding this week, according to Mass High Tech. The company, while still rather under the radar given its sparse website, sounds promising: begun by serial life sciences entrepreneur Amar Sawhney, it is developing space-filling hydrogels [...]
Life sciences took two of the five spots in this week’s Startup Watch from Mass High Tech. The first company spotlighted as one to watch is a unique pharmaceutical company out of Maine called Putney that specializes in drugs for pets. The company says it focuses on developing generics for frequently used drugs where cost [...]
As the International Society for Stem Cell Research (ISSCR) kicked off its annual meeting in Barcelona today, stem cell technology start-up iZumi Bio, a recent Fierce 15 finalist, grabbed headlines with the announcement that it had merged with Pierian, another stem cell technology start-up whose founders include three Harvard faculty members.
The newly formed company, called [...]